MiNK Therapeutics, Inc. (INKT) Operating income 2020–2025
MiNK Therapeutics, Inc. (INKT) annual operating income history from SEC filings — each fiscal year as reported.
-$12.6MFY2025 · since FY2020: -$14.6M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | -12.0% |
| FY2024 | -$11.3M | +50.8% |
| FY2023 | -$22.9M | +25.9% |
| FY2022 | -$30.9M | -9.1% |
| FY2021 | -$28.4M | -93.7% |
| FY2020 | -$14.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INKT financial trends
INKT RevenueINKT Net incomeINKT Net marginINKT Gross profitINKT Gross marginINKT Operating marginINKT Operating cash flowINKT Free cash flowINKT Capital expendituresINKT Return on equityINKT Stock buybacksINKT Dividends paidINKT Total assetsINKT Total liabilitiesINKT Shareholders’ equityINKT overview →